Singular v Dual inhibition of SNF2L and its isoform, SNF2LT, have: Similar effects on DNA Damage but opposite effects on the DNA: Damage response, cancer cell growth arrest and apoptosis

Oncotarget

Volumn 3, Issue 4, 2012, Pages 475-489

  Ye, Yin ^a   Xiao, Yi ^b   Wang, Wenting ^b   Gao, Jian Xin ^b   Yearsley, Kurtis ^b   Yan, Quintao ^b   Barsky, Sanford H ^a,c,d  

^a UNIVERSITY OF NEVADA SCHOOL OF MEDICINE   (United States)

^b THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^c Whittemore Peterson Institute   (United States)

^d NEVADA CANCER INSTITUTE   (United States)

Author keywords

DNA damage; NURF; SNF2l; SNF2lt

Indexed keywords

APOPTOSIS; ARTICLE; CANCER CELL; CELL CYCLE CHECKPOINT; CELL GROWTH; CONTROLLED STUDY; DNA DAMAGE; GENE; GENE FUNCTION; GENE LOCATION; GENE OVEREXPRESSION; GENE SILENCING; GENETIC VARIABILITY; HUMAN; HUMAN TISSUE; MOLECULAR DYNAMICS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; SNF2L GENE; SNF2LT GENE; CELL CYCLE; CELL TRANSFORMATION; CHROMATIN ASSEMBLY AND DISASSEMBLY; DRUG ANTAGONISM; GENETICS; METABOLISM; NEOPLASM; PATHOLOGY; TUMOR CELL LINE;

DNA BINDING PROTEIN; ISOPROTEIN; SMALL INTERFERING RNA; SMARCA1 PROTEIN, HUMAN; TRANSCRIPTION FACTOR;

APOPTOSIS; CELL CYCLE; CELL GROWTH PROCESSES; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; CHROMATIN ASSEMBLY AND DISASSEMBLY; DNA DAMAGE; DNA-BINDING PROTEINS; HUMANS; NEOPLASMS; PROTEIN ISOFORMS; RNA, SMALL INTERFERING; TRANSCRIPTION FACTORS;

EID: 84867181739     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.479     Document Type: Article

References (43)

1. Jones PA, Baylin SB: The epigenomics of cancer. Cell 2007, 128:683-692
2. Nan X, Ng HH, Johnson CA, Laherty CD, Turner BM, Eisenman RN, Bird A: Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature 1998, 393:386-389
3. Jones PL, Veenstra GJ, Wade PA, Vermaak D, Kass SU, Landsberger N, Strouboulis J, Wolffe AP: Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription. Nat Genet 1998, 19:187-191
4. Zhang Y, Ng HH, Erdjument-Bromage H, Tempst P, Bird A, Reinberg, D. Analysis of the NuRD subunits reveals a histone deacetylase core complex and a connection with DNA methylation. Genes Dev 1999, 13:1924-1935
5. Harikrishnan KN, Chow MZ, Baker EK, Pal S, Bassal S, Brasacchio D, Wang L, Craig JM, Jones PL, Sif S, El-Osta A: Brahma links the SWI/SNF chromatin-remodeling complex with MeCP2-dependent transcriptional silencing. Nat Genet 2005, 37:254-264
6. Downs JA, Allard S, Jobin-Robitaille O, Javaheri A, Auger A, Bouchard N, Kron SJ, Jackson SP, Cote J: Binding of chromatin-modifying activities to phosphorylated histone H2A at DNA damage sites. Mol Cell 2004, 16:979-990
7. Morrison AJ, Shen X: DNA repair in the context of chromatin. Cell Cycle 2005, 4:568-571
8. Morrison AJ, Highland J, Krogan NJ, Arbel-Eden A, Greenblatt JF, Haber JE, Shen X: INO80 and g-H2AX interaction links ATP-dependent chromatin remodeling to DNA damage repair. Cell 2004, 119:767-775
9. van Attikum H, Fritsch O, Hohn B, Gasser SM: Recruitment of the INO80 complex by H2A phosphorylation links ATPdependent chromatin remodeling with DNA double-strand break repair. Cell 2004, 119:777-788
10. Wong LY, Recht J, Laurent BC: Chromatin remodeling and repair of DNA double-strand breaks. J Mol Histol 2006, 37:261-269
11. Li H, Ilin S, Wang W, Duncan EM, Wysocka J, Allis CD, Patel DJ: Molecular basis for site-specific read-out of histone H3K4me3 by the BPTF PHD finger of NURF. Nature 2006, 442:91-95
12. Groth A, Rocha W, Verreault A, Almouzni G: Chromatin challenges during DNA replication and repair. Cell 2007, 128:721-733
13. Eisen JA, Sweder KS, Hanawalt PC: Evolution of the SNF2 family of proteins: subfamilies with distinct sequences and functions. Nucleic Acids Res 1995, 23: 2715-2723
14. Chai J, Charboneau AL, Betz BL, Weissman BE: Loss of the hSNF5 gene concomitantly inactivates p21CIP/ WAF1 and p16INK4a activity associated with replicative senescence in A204 rhabdoid tumor cells. Cancer Res 2005, 65: 10192-10198
15. Roberts CW, Orkin SH: The SWI/SNF complex-chromatin and cancer. Nat Rev Cancer 2004, 4:133-142
16. Eberharter A, Vetter I, Ferreira R, Becker PB: ACF1 improves the effectiveness of nucleosome mobilization by ISWI through PHD-histone contacts. EMBO J 2004, 23:4029-4039
17. Wang GG, Allis D, Chi P: Chromatin remodeling and cancer, part II: ATP-dependent chromatin remodeling. Trends in Molecular Medicine 2007, 13: 373-380
18. Bouazoune K, Brehm A: ATP-dependent chromatin remodeling complexes in Drosophila. Chromosome Research 2006, 14:433-449
19. Tsukiyama T, Wu C: ISWI, a member of the SWI2/ SNF2 ATPase family, encodes the 140 kDa subunit of the nucleosome remodeling factor. Cell 1995, 83: 1011-1020
20. Tsukiyama T, Daniel C, Tamkun J, Wu C: Purification and properties of an ATP-dependent nucleosome remodeling factor. Cell 1995, 83:1021-1026
21. Ye Y, Xiao Y, Wang W, Wang Q, Yearsley K, Wani AA, Yan Q, Gao JX, Shetuni BS, Barsky SH: Inhibition of expression of the chromatin remodeling gene, SNF2L selectively leads to DNA damage, growth inhibition and cancer cell death. Mol Cancer Res 2009, 7:1984-1999
22. Barak O, Lazzaro MA, Cooch NS, Picketts DJ, Shiekhattar R: A tissue-specific, naturally occurring human SNF2L variant inactivates chromatin remodeling. J Biol Chem 2004, 279:45130-45138
23. Pepin D, Vanderhyden BC, Picketts DJ, Murphy BD: ISWI chromatin remodeling in ovarian somatic and germ cells: revenge of the NURFs. Trends Endocrinol Metab 2007, 18:215-224
24. Wysocka J, Swigut T, Xiao H, Milne TA, Kwon SY, Landry J, Kauer M, Tackett AJ, Chait BT, Badenhorst P, Wu C, Allis CD: A PHD finger of NURF couples histone H3 lysine 4 trimethylation with chromatin remodelling. Nature 2006, 442:86-90
25. Okabe I, Bailey LC, Attree O, Srinivasan S, Perkel J, Laurent BC, Carlson M, Nelson DL, Nussbaum RL: Cloning of human and bovine homologs of SNF2/SWI2: a global activator of transcription in yeast S. cerevisiae. Nucl Acids Res 1992, 20:4649-4655
26. Alpaugh ML, Tomlinson JS, Shao ZM, Barsky SH: A novel human xenograft model of inflammatory breast cancer. Cancer Res 1999, 59:5079-5084
27. Tomlinson JS, Alpaugh ML, Barsky SH: An intact overexpressed E-cadherin/alpha,beta-catenin axis characterizes the lymphovascular emboli of inflammatory breast carcinoma. Cancer Res 2001, 61:5231-5241
28. Barsky SH: Myoepithelial mRNA expression profiling reveals a common tumor suppressor phenotype. Experimental and Molecular Pathology 2003, 74:113-122, 2003
29. Shimada M, Nakanishi M: DNA damage checkpoints and cancer. J Mol Hist 2006, 37:253-260
30. Sherr CJ: Cancer cell cycles. Science 1996, 274:1672-1677
31. Mohamed MA, Greif PA, Diamond J, Sharaf O, Maxwell P, Montironi R, Young RA, Hamilton PW: Epigenetic events, remodelling enzymes and their relationship to chromatin organization in prostatic intraepithelial neoplasia and prostatic adenocarcinoma. BJU Int 2007, 99:908-915
32. Ito T, Bulger M, Pazin MJ, Kobayashi R, Kadonaga JT: ACF, an ISWI-containing and ATP-utilizing chromatin assembly and remodeling factor. Cell 1997, 90:145-155
33. Osley MA, Tsukuda T, Nickoloff JA: ATP-dependent chromatin remodeling factors and DNA damage repair. Mutat Res 2007, 618:65-80
34. Lazzaro M A, Picketts D J: Cloning and characterization of the murine Imitation Switch (ISWI) genes: differential expression patterns suggest distinct developmental roles for Snf2h and Snf2l. J Neurochem 2001, 77:1145-1156
35. Lazzaro MA, Pepin D, Pescador N, Murphy BD, Vanderhyden BC, Picketts DJ: The imitation switch protein SNF2L regulates steroidogenic acute regulatory protein expression during terminal differentiation of ovarian granulosa cells. Mol Endocrinol 2006, 20:2406-2417
36. Ye Y, Tian H, Lange AR, Yearsley K, Robertson FM, Barsky SH: The genesis and unique properties of the lymphovascular tumor embolus are because of calpainregulated proteolysis of E-cadherin. Oncogene, epub ahead of print 14 May 2012, DOI 10.1038/onc.2012.180
37. Tsukiyama T, Palmer J, Landel CC, Shiloach J, Wu C: Characterization of the imitation switch subfamily of ATPdependent chromatin-remodeling factors in Saccharomyces cerevisiae. Genes Dev 1999, 13:686-697
38. Downs JA, Allard S, Jobin-Robitaille O, Javaheri A, Auger A, Bouchard N, Kron SJ, Jackson SP, Cote J: Binding of chromatin-modifying activities to phosphorylated histone H2A at DNA damage sites. Mol Cell 2004, 16:979-990
39. Levine AJ: p53, the cellular gatekeeper for growth and division. Cell 1997, 88:323-331
40. Chan TA, Hermeking H, Lengauer C, Kinzler KW, Vogelstein B: 14-3-3 Sigma is required to prevent mitotic catastrophe after DNA damage. Nature 1999, 401:616-620
41. Varga-Weisz PD, Wilm M, Bonte E, Dumas K, Mann M, Becker PB: Chromatin-remodelling factor CHRAC contains the ATPases ISWI and topoisomerase II. Nature 1997, 388:598-602
42. Kwon HS, Lim HW, Wu J, Schnölzer M, Verdin E, Ott M: Three novel acetylation sites in the foxp3 transcription factor regulate the suppressive activity of regulatory T cells. J Immunol 2012, 188:2712-2721
43. Beutler B, Jiang Z, Georgel P, Crozat K, Croker B, Rutschmann S, Du X, Hoebe K: Genetic analysis of host resistance: Toll-like receptor signaling and immunity at large. Annu Rev Immunol 2006, 24:353-389.